Used as a key intermediate in pharmaceutical synthesis, particularly in the preparation of kinase inhibitors and other bioactive molecules. Its boronic acid functional group enables Suzuki-Miyaura cross-coupling reactions, allowing for efficient carbon-carbon bond formation in drug development. Commonly employed in the synthesis of investigational compounds targeting inflammatory diseases, cancer, and central nervous system disorders. The presence of fluorine and methoxy substituents enhances binding selectivity and metabolic stability in final active pharmaceutical ingredients.